Upcoming Allied Market Research
Injection Thymopentin Market

Injection Thymopentin Market

by Application (Tumors, Hepatitis, Others), by Distribution Channel (Retail Pharmacy, Online Pharmacy, Others) by End-Users (Hospitals, Clinics, Research Institutes, Other) : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A50464
Pages: NA
Apr 2023 | 102 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

Thymopentin is a type of immunostimulant drug. This drug stimulate or enhance the activity of the immune system by triggering off or increasing the functioning of one of its components. Thymopentin has immunomodulating properties and is a synthetic pentapeptide. It helps in the synthesis of thymic T cells, which are responsible for cell-mediated immunity. This drug is used for a patient with suppressed immunity to increase immunocompetence. It has a short plasma half-life of 30 seconds and is therefore available as an injectable. This is the subject of various clinical studies for the prevention and treatment of hepatocellular cancer and HIV infections.
The injection thymopentin market is anticipated to grow in the forecast period. As stated by World Health Organization, at the end of 2021, there were nearly 38.4 million HIV-positive patients globally. According to estimates, 0.7% of adults, between the ages of 15-49 are HIV positive. The prevalence of AIDS and the mortality rate associated with it may act as a driving force for the injection thymopentin market share. There is an increased demand for immunostimulants, which may help to fight such diseases. This can also be employed for the treatment of hepatocellular carcinoma, the most common type of liver cancer. Currently, several clinical trials and ongoing studies supporting the use of thymopentin injections for the treatment of hepatocellular cancer and HIV infections are in action, thus expanding the injection thymopentin market. The market for this may potentially be fueled by the increase in demand for downstream and single-use products. In the wake of the COVID-19 pandemic, there has been an increase in R&D activities which may create new opportunities for this market.
Although the injection thymopentin market is anticipated to expand in the coming years, there may be some challenges to the market. Thymopentin may be associated with a few side effects like nausea, fever, dizziness, chest distress, and minor adverse reactions in some cases. Alternate therapies, with fewer side effects, are available that may cause some hindrances in the growth of this market. Other than this, immunostimulants may be expensive due to their manufacturing process, thus not affordable for everyone. This may reduce the target population for thymopentin and therefore restrict the growth of the market.
There has been a hike in the R&D for thymopentin that is anticipated to provide lucrative opportunities for players to increase their market share in the injection thymopentin market. Numerous pharmaceuticals have started an initiative to discover newer trends that may benefit the people. Also, there has been rising health expenditure all over the global, chiefly in countries like the U.S., due to the prevalence of diseases of the immune system. This may also act as an opportunity to increase the market share of this market.
New product launches to flourish in the market
A study has been conducted at Liver Cancer Institute and Zhongshan Hospital, Fudan University, China to assess the efficacy of thymopentin for the prevention of the relapse and metastasis of hepatocellular cancer after excision. It was carried out for five years in a randomized allocation. Nearly 220 participants between the age groups of 18 Years to 75 Years took part in the study. This study produced a favorable result, with the primary outcome being disease-free survival for almost three years and the secondary outcome of overall survival for three years. 
Segment Overview: 
By application type: The injection thymopentin market is classified as tumors, hepatitis, and others. The tumor cases witnessed a sudden rise in the last few years. This has led to an urgent need for a potential treatment approach. The inflammation of the liver, caused by the hepatitis virus has infected nearly 354 million people globally. These viruses are of five types: namely A, B, C, D, and E. The use of thymopentin with antituberculosis drugs for the treatment of drug-resistant pulmonary tuberculosis is also under study.
By distribution channel: The injection thymopentin market is divided into retail pharmacy, online pharmacy, and others. In recent years, online pharmacies have become more popular. To avoid visiting a physical pharmacy, majority of people choose to obtain their drugs online. But these distribution channels have some disadvantages. There have been several cases of unregistered or unlicensed pharmacies dispensing inaccurate drugs. A retail pharmacy is an individual pharmacy or a set of pharmacies that is run by a pharmacist licensed by that particular state. 
By end-users: The injection thymopentin market is categorized into hospitals, clinics, research institutes, and other. Since there is an increase in the prevalence of hepatocellular carcinoma and HIV cases, various research institutes are involved in the study of the efficacy of thymopentin for these diseases. In hospitals, thymopentin injections are mainly used to boost the immunity of an immunocompromised patient.
Competitive analysis and profiles of the major players in the injection thymopentin market, such as Active Peptide Company, Cisen pharmaceutical Co. ltd., Graton Pharma, Hainan Zhonghe Pharmaceutical Co. Ltd, Hybio Pharmaceutical Co. Ltd, Jiangsu Kingsley Pharmaceutical Co. Ltd, Santa cruz biotechnology, Shanghai Huayuan Pharmacy, Sinopharm A-Think Pharmaceutical Co., and Yangtze River Pharmaceutical Group are provided in this report. Merck KGaA is also one of the key market players in the injection thymopentin market 

Injection Thymopentin Market Report Highlights

Aspects Details
By Application
  • Tumors
  • Hepatitis
  • Others
By Distribution Channel
  • Retail Pharmacy
  • Online Pharmacy
  • Others
By End-Users
  • Hospitals
  • Clinics
  • Research Institutes
  • Other
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players santa cruz biotechnology, Active Peptide Company, Yangtze River Pharmaceutical Group, Graton Pharma, Hainan Zhonghe Pharmaceutical Co.,Ltd, Hybio Pharmaceutical Co.,Ltd, Shanghai Huayuan Pharmacy, Jiangsu Kingsley Pharmaceutical Co., Ltd, Sinopharm A-Think Pharmaceutical Co., cisen pharmaceutical co., ltd.
Merck KGaA

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Injection Thymopentin Market

Start reading.
This Report and over 19,950+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,600
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers